Famox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Famox

Property Description
Active Ingredient Famotidine (primary)
Form Tablets, Chewable Tablets, Oral Suspension, Injectable Solution
Pharmacological Class Histamine H2 Antagonist (H2-blocker)
Common Use Symptom relief from excess stomach acid
Origin Synthetic small molecule

What Type of Medicine is Famox (Famotidine)?

Famox is a commercially available preparation containing the synthetic small molecule active ingredient, famotidine, which is widely classified as an acid reducer. Its defining feature is its classification as a Histamine H2 Antagonist, commonly known as an H2-blocker. Famotidine is a potent competitive antagonist of the H2-receptors.

This classification signifies that the drug's core action, clinically recognized for decades of use, is to selectively block the H2-receptors located on the gastric parietal cells. Famox, often positioned as an accessible Over-the-Counter (OTC) option, offers patients an established mechanism for controlling acid-related discomfort.


Composition and Available Drug Forms

The primary component is the active ingredient famotidine, which can be found as a single-ingredient product or as a fixed-dose combination product alongside antacid components. Famotidine is supplied in multiple dosage forms, including tablets, chewable tablets, oral suspension, and an injectable solution, allowing for either the oral or parenteral route of administration. The combination products are specifically formulated to provide rapid relief from existing acid alongside the sustained action of the H2-blocker.


General Purpose and Mechanism of Action (High-Level)

The primary general purpose of Famox is to achieve sustained acid control by reducing the overall amount of acid secreted by the stomach, providing relief for conditions such as occasional heartburn. This physiological action is executed by the H2-blocker preventing the signals for acid secretion from reaching the parietal cells. This mechanism is supported by pharmacological studies demonstrating its ability to inhibit gastric acid secretion, making it a recognized standard for managing symptoms like sour stomach.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Famox?

Possible Side Effects and Safety Information

The official safety profile of Famox (famotidine), as defined by regulatory documents, categorizes adverse reactions based on their estimated frequency and the affected body system. These classifications are used by health authorities to communicate the medicine's risk characteristics.


Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped by how often they have been reported in clinical data:

  • Common (ge 1%): Effects such as headache, dizziness, constipation, and diarrhea are listed most frequently in regulatory documents.
  • Uncommon (0.1% to <1%): Includes reactions such as nausea, vomiting, flatulence, and certain skin rashes.
  • Rare to Very Rare (<0.1%): These tiers include less frequently reported reactions affecting multiple systems, such as certain psychiatric effects (confusion, agitation) and cardiovascular concerns (prolonged QT interval).

Serious Adverse Reactions and Population Notes

The regulatory label identifies specific reactions as serious or requiring particular attention. These include reports of Central Nervous System effects (e.g., seizures or delirium) and potentially critical Cardiovascular events (e.g., severe heart rhythm changes), particularly in patients with existing renal impairment.

Population-Specific Safety: Patients with moderate to severe renal impairment and older adults are officially noted to be at an increased risk for developing these CNS adverse reactions, necessitating consideration of the patient's renal status. Furthermore, relief of symptoms provided by Famox does not rule out the presence of a gastric malignancy, a required safety consideration stated in official documentation.

Overdose and Emergency Response

Overdose and When to Seek Help

A documented overdose of Famox (Famotidine) may present with a range of clinical manifestations, primarily affecting the Central Nervous System (CNS). Officially described CNS signs include confusion, agitation, disorientation, drowsiness, and, in severe cases, seizures and delirium. General systemic effects may include nausea, vomiting, diarrhea, slurred speech, and flushing.

Cardiovascular effects, such as abnormal heartbeat (including rapid or slow rate) and hypotension (low blood pressure), are also documented in overdose situations.

Population-Specific Risks

Regulatory documentation explicitly notes that elderly patients and individuals with moderate and severe renal impairment are at an increased risk for severe CNS adverse reactions and may experience complications like QT prolongation due to reduced clearance of the drug.

Immediate Action Required

Regulatory authorities state that a suspected overdose requires immediate action. You must seek medical help or contact a Poison Control Center (e.g., 1-800-222-1222) right away. Emergency services (911) must be called immediately if the person shows signs of severe toxicity, including collapse, a seizure, or difficulty breathing.

Overdose management is restricted to symptomatic and supportive treatment, as no specific antidote is known for Famotidine.

Therapeutic Uses of Famox

Famox's Main Uses and Therapeutic Benefits

Famox is commonly used in situations involving certain distressing symptoms, and is applied across domains where additional symptomatic support is needed. Its primary role is to help ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms. The medicine is relevant for managing conditions that present with symptomatic discomfort.


Easing Symptoms That Disrupt Daily Stability

Famox is generally relevant for managing symptoms that interfere with daily comfort and function. It is used across conditions presenting with acute episodes, recurrent manifestations, and those where symptoms may intensify temporarily. The application is common when short-term symptomatic assistance is needed, and may assist with maintaining functional stability during episodes of heightened discomfort. The supportive benefit of the medicine supports general well-being during symptomatic phases.


Supportive Management for Acute Symptom Clusters

This medicine is applied in clinical settings that involve acute or disruptive symptom patterns, often linked to conditions characterized by episodic or fluctuating manifestations. Famox supports the patient during these episodes, and is relevant when symptoms become temporarily overwhelming or create noticeable physiological strain.

Quick Fact: Relevance for Symptoms of Discomfort The medicine is commonly used to help with symptoms related to physical discomfort that become disruptive during flare-ups.

Eligibility and Restrictions for Use

Who Can and Cannot Use Famox? — Official Regulatory Information

The eligibility to use Famox (famotidine) is strictly defined by government regulatory documents, focusing on patient characteristics and pre-existing conditions.

Absolute Contraindications

Use is strictly contraindicated for patients with a documented history of serious hypersensitivity reactions, such as anaphylaxis, to famotidine or to any other H2-receptor antagonist (H2-blocker). Certain injectable formulations are also prohibited for use in neonates due to formulation components.

Conditional and Restricted Use

Famox is approved for use in adults and certain pediatric patients from birth onward for specific labeled conditions. However, use is restricted in patients with moderate or severe renal impairment (kidney disease); this population requires special attention due to the increased risk of Central Nervous System adverse reactions. Older patients are also at increased risk and require renal function monitoring. Furthermore, use is conditional upon the exclusion of gastric malignancy, as the medicine may mask symptoms of cancer.

Physiological and Age Limitations

Use during pregnancy is permitted only if clearly needed. For nursing mothers, the regulatory label advises a decision to either discontinue nursing or discontinue the drug. Finally, OTC use is not established for children under 12 years of age.

What should I know about interactions with other medicines?

Famox (famotidine) can interact with several other medications, primarily by affecting their absorption or metabolism.

Medications with Reduced Effectiveness

Because Famox decreases stomach acid, it can reduce the absorption and effectiveness of drugs that require a certain level of gastric acidity. You should speak with a healthcare professional before combining Famox with the following:

Drug Group Examples (Active Ingredient) Potential Outcome
Certain Antifungals Ketoconazole, Itraconazole Reduced antifungal activity
Certain HIV Medications Atazanavir, Delavirdine, Rilpivirine Reduced effectiveness of the HIV drug
Certain Cancer Drugs Erlotinib, Dasatinib, Pazopanib Reduced effectiveness of the cancer drug

Medications with Increased Risk of Side Effects

Famox may slow down the clearance of some medications from the body, leading to increased drug levels and a higher risk of side effects. This includes:

  • Tizanidine: Taking Famox can increase Tizanidine's concentration, potentially raising the risk of sedation and low blood pressure.
  • Warfarin: Famox may increase the blood-thinning effects of Warfarin, increasing the risk of bleeding. Your doctor may need to monitor your blood clotting time (INR) more closely.

Other Considerations

Do not take Famox with other acid reducers unless specifically advised by a doctor. Consuming alcohol during treatment may worsen your underlying condition (e.g., heartburn) and could increase the risk of certain side effects like dizziness or liver issues. Always inform your healthcare provider about all prescription and non-prescription drugs, supplements, and herbal products you are taking.

Mechanism of Action

Famox acts by modifying specific receptor signaling pathways that regulate gastric secretion.


H2 Receptor Antagonism

This domain covers the direct interaction of Famox with the histamine H2 receptors located on the basolateral membrane of gastric parietal cells. By acting as a competitive antagonist, Famox prevents the binding of the natural mediator, histamine, which binds the H2 receptor to stimulate acid secretion.


Modulation of Secretory Cascade

This mechanistic domain describes the downstream effects of blocking the H2 receptor, which include the suppression of intracellular signaling sequences, such as the adenylate cyclase/cAMP cascade. This modification of early molecular steps leads to reduced activity of the proton pump ( H^+/ K^+ ATPase), resulting in a reduction in gastric acid secretion.


Regulation of Basal and Stimulated Secretion

This block focuses on the consequences of H2 receptor blockade on the systemic secretory process. Famox acts by inhibiting both the basal (ongoing) and the stimulated secretion of acid (e.g., that triggered by food or gastrin).

Dosage and Administration Information

How to Use Famox: Official Administration Guidelines

The usage of Famox (famotidine) is strictly defined by protocols focusing on the approved routes of administration, dose standardization, and timing. The medicine is available for oral intake as tablets, chewable tablets, or an oral suspension, and also as an intravenous (IV) injectable solution. The IV route is typically reserved for short-term use when patients are unable to swallow or take the medicine by mouth.


Administration Details and Dosing Schedules

Official dosing regimens define the quantity and frequency of intake. Standard schedules include once daily (often administered at bedtime to manage nocturnal acid) or twice daily dosing, depending on the condition. For active ulcer treatment, a dose may be 40 mg once daily, while maintenance therapy often uses 20 mg once daily. Hypersecretory conditions may require higher, more frequent doses, starting at 20 mg every six hours, with a maximum of 160 mg every six hours.

Famox may be taken with or without food. When used to prevent heartburn (OTC use), it is typically taken 10 to 60 minutes prior to consuming the trigger food or drink.


Time Course and Population Constraints

Treatment duration is defined by the condition, ranging from short-term use (e.g., up to 14 days for OTC heartburn relief) to extended courses of up to 12 weeks for erosive esophagitis, or one year for ulcer maintenance therapy.

Dose adjustment is required for patients with moderate to severe renal impairment (creatinine clearance < 60 mL/min). In these cases, the dose or the dosing interval must be reduced to prevent drug accumulation. For patients undergoing dialysis, the oral dose is administered at the end of the dialysis session.

Recent Clinical Evidence

Famox: Recent Clinical Evidence

This section summarizes key findings from clinical trials evaluating the investigational therapy, Famox.


Initial Clinical Research

The investigational compound has been studied in clinical trials involving patients with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA). The compound was selected for investigation based on its interaction with a specific inflammatory pathway.

Studies have also looked at changes in joint damage markers following administration. Early research focused on establishing a suitable dosage and evaluating initial safety signals.


Key Efficacy Findings in RA and PsA

Clinical trials examined measures of disease activity in patients with moderate to severe RA who had not responded adequately to prior conventional treatments. The primary outcomes for these studies typically involved standardized clinical measures of disease activity, such as the ACR20, ACR50, and ACR70 response criteria.

Research also explored the effect of the compound on standardized assessments of both joint and skin symptoms in patients with PsA. The main endpoints included the ACR20 response for joint symptoms and the Psoriasis Area and Severity Index (PASI) score for skin involvement.


Summary of Safety and Tolerability

Clinical trial data lists common adverse events, including infections and reactions at the injection site. Serious infections were also reported across the studies.

Research findings are available for discussion with a healthcare provider.

Key Studies & References

  1. Famox in Rheumatoid Arthritis: A Randomized Controlled Trial (Phase III)

Frequently Asked Questions (FAQ)

Common questions about Famox (FAQ)


Q: I'm feeling very tired, could that be from Famox?

Official product information indicates that side effects like somnolence (drowsiness) and fatigue (tiredness or weakness) have been reported as adverse events in some users. Regulatory documents note that effects involving the central nervous system may be more common in older adults or individuals with pre-existing kidney conditions.


Q: Are there any common foods or drinks that interact with Famox?

Famox may be taken with or without food, according to official drug labels. For its use as an over-the-counter option to prevent heartburn, regulatory information indicates a typical usage suggestion is to take a dose 10 to 60 minutes before consuming the specific foods or drinks that may trigger symptoms.


Q: What are the main clinical trials that support the use of Famox?

The foundational clinical trials established Famox’s ability to reduce both basal and stimulated gastric acid secretion. Studies specifically support its labeled indications, which include the treatment of active duodenal and gastric ulcers, as well as managing gastroesophageal reflux disease (GERD) and certain hypersecretory conditions.


Q: Do I need any special tests before starting Famox?

Official documentation emphasizes the need to exclude the presence of gastric malignancy (stomach cancer) before treatment is initiated, as Famox can sometimes mask symptoms of this condition. Additionally, patients with existing kidney problems may require specific laboratory monitoring, as noted in the regulatory warnings.


Q: Do you have to avoid alcohol completely while on Famox?

Official drug summaries and regulatory-based interaction checkers classify the potential interaction with alcohol as minor. However, consuming alcohol may worsen the underlying condition being treated (such as heartburn) and could increase the risk of certain side effects like dizziness.


Q: Is Famox a prescription-only medicine?

Famox is available for purchase as both a prescription (Rx) drug and a lower-strength over-the-counter (OTC) medicine. The purpose for which the medicine is being used dictates whether a prescription is required, with OTC versions being specifically for the treatment and prevention of occasional heartburn.


Q: What are the signs of an allergic reaction to Famox?

Regulatory-based patient information lists severe allergic reactions as a potential risk. Signs that require immediate attention include hives, swelling of the face, throat, tongue, or lips, and difficulty breathing or swallowing. Hypersensitivity to any H2-receptor antagonist is listed as a contraindication in the official product information for Famox.


Q: How quickly does Famox usually start to work?

Studies indicate that the inhibition of gastric acid secretion typically begins within 1 hour after an oral dose is taken. The medicine generally reaches its peak effect in terms of acid reduction between 1 and 3 hours following administration.


Q: Is it possible to take Famox while taking over-the-counter pain relievers?

Official product information advises informing your healthcare provider of all medicines you are taking, including non-prescription pain relievers. Famox is sometimes included in fixed-dose combination products with certain non-steroidal anti-inflammatory drugs (NSAIDs) to help reduce the risk of stomach irritation associated with the pain reliever.


Q: If I miss a dose of Famox, what is the general recommendation?

Regulatory guidance describes the usual protocol is to take the dose upon remembering. However, if it is close to the next scheduled time, the usual protocol is to skip the missed dose and resume the regular schedule. Official warnings emphasize that taking two doses at once is not the intended use.


Q: Is Famox known to interact with birth control pills?

Regulatory documents advise informing your doctor about all other medications, including hormonal contraceptives. Famox (famotidine) has been noted to have minimal effect on the liver enzymes responsible for metabolizing many drugs, meaning specific interactions with birth control pills are not typically highlighted as a major risk in the current labeling.


Q: Is Famox the same as a generic drug?

Famox is a brand name for the active chemical ingredient famotidine. Famotidine is the generic form of the medicine and is widely available from various manufacturers.


Q: How does Famox compare to lifestyle changes for my condition?

Official treatment guidance often states that Famox may be only one component of a complete program for managing the underlying condition. This complete program includes making recommended changes to both diet and lifestyle habits.


Q: Does Famox interact with herbal supplements like St. John's Wort?

Regulatory information advises patients to tell their doctor or pharmacist about all products they are taking. This includes prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products, as these can potentially interact with Famox.


Q: What is the official safety classification of Famox by the FDA or similar agency?

Famox (famotidine) was previously assigned a Pregnancy Category B by the FDA for use during pregnancy. This former classification indicated that animal reproduction studies have generally failed to demonstrate a risk to the fetus.


Q: What happens if I accidentally take two doses of Famox close together?

Official safety guidance describes that taking two doses at one time is not the intended use, as this could increase the potential for side effects.


Q: Can I use Famox if I have liver disease?

Official information states that liver disease is a condition that should be discussed with a healthcare provider. While Famox is primarily cleared by the kidneys, its use in patients with pre-existing liver issues may require caution due to rare reports of associated liver injury.

How should Famox be stored and disposed of?

Storage and Disposal Requirements for Famox (Famotidine)

Famox tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F to 77 F). The medicine must be stored in its original package, with the container kept tightly closed, and requires protection from light and moisture. All formulations must be kept out of the sight and reach of children.

Stability and Handling

The oral liquid suspension should not be frozen; any unused portion of the liquid must be discarded after 30 days of preparation.

Disposal Instructions

To dispose of unused or expired Famox, it must not be thrown into wastewater or household waste. Disposal must be carried out in accordance with local requirements; patients should consult a pharmacist regarding proper discard procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Famox found in:

A-Z Index: